financetom
SYBT
financetom
/
Financials
/
SYBT
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Stock Yards Bancorp, Inc.SYBT
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Stock Yards Bancorp, Inc. operates as a holding company for Stock Yards Bank & Trust Company that provides various financial services for individuals, corporations, and others in the United States.

It operates in two segments, Commercial Banking, and WM&T. The Commercial Banking segment offers mortgage banking and deposit services; retail, commercial, and commercial real estate lending services; and online banking, mobile banking, private banking, leasing, treasury management, merchant, international banking, correspondent banking, and other banking services.

This segment also provides securities brokerage services through an arrangement with a third party broker-dealer.

The WM&T segment provides investment management, financial and retirement planning, and trust and estate services, as well as retirement plan management for businesses and corporations.

It provides services in Louisville, central, eastern, and northern Kentucky, as well as Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets.

The company was founded in 1904 and is headquartered in Louisville, Kentucky.

Latest News >
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Update: ADC Shares Rise After Company Completes Enrollment in Late-Stage Zynlonta Combination Trial
Dec 31, 2024
02:15 PM EST, 12/31/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph) ADC Therapeutics ( ADCT ) gained as much as 4.2% in intraday trading Tuesday after the company said it had completed patient enrollment in its phase 3 confirmatory trial of Zynlonta in combination with rituximab in patients with relapsed or refractory diffuse...
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Legacy Housing Insider Sold Shares Worth $425,099, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Curtis Drew Hodgson, 10% Owner, Director, on December 30, 2024, sold 17,300 shares in Legacy Housing ( LEGH ) for $425,099. Following the Form 4 filing with the SEC, Hodgson has control over a total of 4,173,778 shares of the company, with 404,722 shares held directly and 3,769,056 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1436208/000110465924132810/xslF345X05/tm2432358-1_4seq1.xml...
Boeing on track to be 2024's biggest loser in Dow Jones Index
Boeing on track to be 2024's biggest loser in Dow Jones Index
Dec 31, 2024
(Reuters) - U.S. planemaker Boeing ( BA ) is on track to be the biggest loser of 2024 in the Dow Jones Index, tumbling 32% as it bounced from one crisis to another.  Rival Airbus rose more than 11% for the year, and the benchmark S&P 500 gained more than 23% during 2024.  Boeing's ( BA ) shares opened the...
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Ultragenyx Pharmaceutical Insider Sold Shares Worth $495,231, According to a Recent SEC Filing
Dec 31, 2024
02:11 PM EST, 12/31/2024 (MT Newswires) -- Emil D Kakkis, Director, President & CEO, on December 30, 2024, sold 11,727 shares in Ultragenyx Pharmaceutical ( RARE ) for $495,231. Following the Form 4 filing with the SEC, Kakkis has control over a total of 2,748,590 shares of the company, with 564,605 shares held directly and 2,183,985 controlled indirectly. SEC Filing:...
Copyright 2023-2025 - www.financetom.com All Rights Reserved